Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Loss of c-REL but not NF-?B2 prevents autoimmune disease driven by FasL mutation.

O'Reilly LA, Hughes P, Lin A, Waring P, Siebenlist U, Jain R, Gray DH, Gerondakis S, Strasser A. Loss of c-REL but not NF-?B2 prevents autoimmune disease driven by FasL mutation. Cell Death Differ. 2015 May; 22(5):767-78.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.